As FDA reviews treatment for PTSD.
Companies developing psychedelic drugs are no longer seen as niche investments with key regulatory decisions on the horizon.
“We’ve already seen a meaningful shift in terms of institutional investors’ interest in the space, and that should only broaden,” Jiang said, speaking on a panel about funding prospects for the industry. He said he’s noticed more participation among those who don’t specialize in psychedelics in recent funding rounds of companies including Cybin Inc, which raised $150 million in March, and Mind Medicine Inc, which had a $175 million private placement.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Liberia: About U.S.$ 3 Million Made From Planks Unaccounted for At FDATitus Buah was very excited about his new assignment as the supervisor for a checkpoint in Big Joe Town, Grand Bassa County. It was a busier, bigger and more beneficial assignment for a checkpoint contractor with the Forestry Development Authority (FDA).
Read more »
Liberia: EPA, FDA & Partners Brainstorm On Multi-Level Climate Governance StrategyGovernment of Liberia strategizes on Climate Change regime.
Read more »
SAA wants investors on board – but government in the cockpitSouth African Airways is still open to bringing a private equity partner on board — but government is not giving up control.
Read more »
ITWeb TV: Luno shifts focus to business, institutional investorsAfter recently receiving a financial services provider licence, the crypto exchange is looking to diversify its product offerings.
Read more »
SA's MTI scandal: US lawyers now want money back from 150 bitcoin investorsSA's MTI scandal: US lawyers now want money back from 150 bitcoin investors
Read more »
Sygnia ETF changes: What investors need to knowHolders of The Fourth Industrial Revolution and the Faang AI ETFs need to ‘look under the hood’ to fully understand the impending differences and implications.
Read more »